CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride Overview

Managing complex upper respiratory tract infections, paranasal sinus inflammation, and acute allergic rhinitis frequently requires addressing localized pain, fever, mucosal hyper-reactivity, and profound sinus congestion simultaneously. The fixed-dose combination of Chlorpheniramine Maleate, Ibuprofen, and Pseudoephedrine Hydrochloride is an FDA-approved oral multi-symptom formulation. Used across general medicine, primary care, and outpatient pediatrics, this triple-action medication provides temporary relief from multi-symptom cold, sinus, and upper respiratory allergic conditions.

What Is Chlorpheniramine, Ibuprofen, and Pseudoephedrine and How Does It Work?

This triple-combination product delivers multi-symptom relief through three distinct, synergistic mechanisms of action:

Ibuprofen is a non-selective propionic acid NSAID that reversibly inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes. This enzyme inhibition decreases the peripheral synthesis of inflammatory prostaglandins from arachidonic acid, suppressing nociceptive pain signaling, reducing sinus headache and facial pressure, easing sore throat discomfort, lowering systemic pyrexia, and reducing localized tissue swelling within paranasal passages.

Is Chlorpheniramine, Ibuprofen, and Pseudoephedrine FDA Approved?

Yes, Chlorpheniramine Maleate, Ibuprofen, and Pseudoephedrine Hydrochloride formulations are fully FDA approved. The combination received its initial formal regulatory approval under application NDA 021441 in (December 2002) and serves as an over-the-counter multi-symptom therapeutic option.

What Is Chlorpheniramine, Ibuprofen, and Pseudoephedrine Used For?

• Multi-Symptom Sinus and Allergy: Temporary relief of sinus headache, sinus pressure, fever, facial pain, nasal congestion, sneezing, rhinorrhea, and itchy, watery eyes associated with allergic rhinitis or sinusitis.
• Cold and Flu Symptoms: Temporary clearance of blocked nasal passages, paranasal sinus pressure, minor body aches, sore throat, and sneezing accompanying viral upper respiratory infections.

Before Taking Chlorpheniramine, Ibuprofen, and Pseudoephedrine: Contraindications & Precautions

Because this product contains an NSAID, a sedating antihistamine, and a potent sympathomimetic decongestant, thorough screening for cardiovascular, gastrointestinal, renal, and neurological risk factors is mandatory.

Who Should Not Take This Combination?

• Aspirin Triad / NSAID Hypersensitivity: Strictly contraindicated in patients with a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs due to severe, potentially fatal anaphylactoid reactions.
• Perioperative Coronary Artery Bypass Graft (CABG) Surgery: Contraindicated for the treatment of perioperative pain in the setting of CABG surgery.
• Monoamine Oxidase Inhibitor (MAOI) Therapy: Strictly contraindicated in patients currently taking MAOIs or within 14 days of discontinuing MAOI therapy due to the risk of precipitating a fatal hypertensive crisis.
• Severe Cardiovascular Disease: Contraindicated in patients with severe uncontrolled hypertension, severe coronary artery disease, or lethal cardiac dysrhythmias.
• Glaucoma and Urinary Retention: Contraindicated in patients with narrow-angle glaucoma or severe urinary retention associated with prostatic hypertrophy.

Pregnancy, Fertility & Lactation

Ibuprofen use during pregnancy carries significant risks. Avoid use in pregnant women starting at 20 weeks gestation because NSAIDs may cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios. Use during late pregnancy (third trimester) is strictly contraindicated. Pseudoephedrine has also been associated in early pregnancy with rare fetal vascular disruption defects. Both chlorpheniramine and pseudoephedrine pass into human breast milk; pseudoephedrine can suppress lactation and cause irritability in nursing infants.

Tell Your Doctor Before Taking This Medication

Patients must disclose a complete clinical history before starting treatment. Inform your doctor or pharmacist if you have a history of peptic ulcer disease, gastrointestinal bleeding, hypertension, congestive heart failure, fluid retention, chronic kidney disease, hepatic dysfunction, asthma, hyperthyroidism, diabetes mellitus, elevated intraocular pressure, or prostatic hypertrophy. Disclose all concurrent medications, particularly blood pressure lowering drugs, anticoagulants, antiplatelet agents, systemic corticosteroids, or other NSAIDs.

Chlorpheniramine, Ibuprofen, and Pseudoephedrine Dosage & Administration

This multi-symptom combination is available as adult oral tablets and pediatric liquid suspensions.

Standard Adult Dosing (12 Years and Older)

• Standard Adult Dose (Tablets): One tablet (2 mg chlorpheniramine maleate / 200 mg ibuprofen / 30 mg pseudoephedrine hydrochloride) taken orally every 4 to 6 hours while symptoms persist.
• Maximum Recommended Daily Dose: Do not exceed 4 tablets within a 24-hour period unless directed by a physician.

Pediatric Dosing (Children’s Suspension Formulations)

• Children 6 to 11 Years: Administer using an accurate calibrated dosing cup based on weight or age according to product label instructions (typically 10 mL of suspension containing 2 mg chlorpheniramine / 200 mg ibuprofen / 30 mg pseudoephedrine every 6 hours).
• Children Under 6 Years: Not recommended unless under the direct supervision and authorization of a pediatrician.

How to Take This Medication

• Take each dose with a full glass of water. Shake liquid suspensions well before measuring.
• Taking this medication with food, milk, or an antacid can help minimize mild gastrointestinal stomach upset caused by the ibuprofen component.
• Shortest Duration Principle: Use the lowest effective dose for the shortest possible duration to minimize cardiovascular, gastrointestinal, and renal risks. Do not use for more than 7 days for cold/sinus symptoms or 3 days for fever without medical re-evaluation.

Chlorpheniramine, Ibuprofen, and Pseudoephedrine Clinical Efficacy & Research

Clinical trials evaluating multi-ingredient respiratory products confirm that combining an NSAID, an H1-antagonist, and a sympathomimetic decongestant delivers significantly superior overall symptom relief compared to monotherapy or dual combinations. Pharmacodynamic research demonstrates that ibuprofen effectively suppresses pain, pyrexia, and localized sinus inflammation. Simultaneously, pseudoephedrine provides sustained reduction of nasal airflow resistance and sinus passage edema, and chlorpheniramine attenuates histamine-mediated rhinorrhea and sneezing. Clinical studies show high patient satisfaction scores for rapid relief of complex upper respiratory allergic and sinus conditions.

Chlorpheniramine, Ibuprofen, and Pseudoephedrine Side Effects & Safety Profile

The adverse event profile reflects the combined safety profiles of its three active components, encompassing gastrointestinal, cardiovascular, and central nervous system effects.

• Cardiovascular Risk: NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use.
• Gastrointestinal Risk: NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk.

Common Side Effects (>10%)

• Mild gastrointestinal discomfort, heartburn, nausea, or abdominal pain.
• Central nervous system effects: insomnia, nervousness, restlessness, or mild dizziness from pseudoephedrine, balanced by potential somnolence from chlorpheniramine.
• Dryness of the mouth, nose, and throat.

Serious Adverse Events

• Cardiovascular complications: significant blood pressure elevations, severe sinus tachycardia, palpitations, cardiac dysrhythmias, myocardial infarction, or stroke.
• Gastrointestinal ulceration, severe upper GI bleeding, or intestinal perforation.
• Renal impairment: acute kidney injury, fluid retention, edema, or papillary necrosis.
• Severe cutaneous adverse reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or drug reaction with eosinophilia and systemic symptoms (DRESS).
• Severe hypersensitivity reactions: anaphylaxis, angioedema, or acute bronchospasm.
• Genitourinary impairment: acute urinary retention or dysuria.

Managing Side Effects

Take doses with food or milk to lessen stomach distress. Avoid taking doses close to bedtime to minimize pseudoephedrine-induced insomnia. If severe stomach pain, black or tarry stools, vomiting blood, sudden chest pain, shortness of breath, severe hypertension, skin rash, or difficulty urinating develop, discontinue the medication immediately and seek emergency medical care.

Chlorpheniramine, Ibuprofen, and Pseudoephedrine Drug Interactions & What to Avoid

Interactions with this combination involve potential cardiovascular, gastrointestinal, renal, and central nervous system hazards.

Drug-Drug Interactions

• Monoamine Oxidase Inhibitors (MAOIs): Co-administration with MAOIs or within 14 days of stopping them is strictly contraindicated due to the risk of severe, life-threatening hypertensive crisis.
• Anticoagulants (Warfarin, Direct Oral Anticoagulants) and Antiplatelet Agents (Aspirin, Clopidogrel): Concomitant use with ibuprofen dramatically increases the risk of severe gastrointestinal bleeding.
• Antihypertensives, Beta-Blockers, ACE Inhibitors, and Diuretics: Ibuprofen blunts the blood pressure-lowering effect of antihypertensives and increases acute renal failure risks. Pseudoephedrine directly opposes antihypertensive efficacy.
• Digitalis and Antiarrhythmics: Co-administration with pseudoephedrine increases the risk of ectopic cardiac pacemaker activity and dysrhythmias.
• CNS Depressants and Alcohol: Additive sedation occurs when chlorpheniramine is combined with alcohol, tranquilizers, or sedatives.

Alcohol Warning

Avoid alcohol while taking this medication. Consuming three or more alcoholic drinks daily while taking ibuprofen significantly increases the risk of severe stomach bleeding. Additionally, alcohol enhances central nervous system instability when combined with pseudoephedrine and chlorpheniramine.

Chlorpheniramine, Ibuprofen, and Pseudoephedrine: Missed Dose, Overdose & Storage

Missed Dose

If you miss a dose, take it as soon as you remember, provided it is not close to your next scheduled dose. If it is nearly time for your next dose, skip the missed dose and resume your regular schedule. Do not double up doses or take extra medicine to make up for a missed dose.

Overdose & Emergency

Overdosage manifests as mixed toxicity involving NSAID, antihistamine, and severe sympathomimetic features. Symptoms include severe nausea, vomiting, epigastric pain, GI bleeding, lethargy, severe hypertension, severe tachycardia, palpitations, chest pain, tremors, agitation, seizures, metabolic acidosis, renal failure, and CNS depression or hyper-excitation. In case of suspected overdose, seek emergency medical care immediately or contact a poison control center. Treatment consists of supportive care, activated charcoal if presenting early, cardiac monitoring, and acid-base stabilization.

Storage Instructions

Store tablets and oral suspensions at controlled room temperature between 20 degrees Celsius and 25 degrees Celsius (68 degrees Fahrenheit to 77 degrees Fahrenheit). Avoid excessive heat above 40 degrees Celsius (104 degrees Fahrenheit) and protect from high humidity and light. Keep in original packaging and store safely out of reach of children and pets.

Chlorpheniramine, Ibuprofen, and Pseudoephedrine Patient Management & Monitoring

Safe use requires assessing cardiovascular and gastrointestinal risk, ensuring correct dosing intervals, and monitoring for adverse events.

Clinical Assessment Before Starting Treatment

• Evaluation of baseline blood pressure, cardiovascular status, and history of GI bleeding or ulcers.
• Screening for recent MAOI use, asthma, aspirin allergy, or urinary retention risk.
• Verification of patient age to ensure appropriate formulation selection (adult vs pediatric).

Monitoring During Treatment

• Monitoring for clinical relief of pain, fever, sinus congestion, and allergic symptoms.
• Observing for signs of GI distress, dark stools, elevated blood pressure, or unusual swelling.
• Tracking duration of treatment to ensure it does not exceed recommended limits (7 days for cold/sinus, 3 days for fever).

Do’s and Don’ts

• DO take each dose with food or milk to help protect your stomach.
• DO purchase behind the pharmacy counter as required by regulations governing pseudoephedrine sales.
• DON’T exceed 4 tablets within a 24-hour period for adults.
• DON’T take concurrently with other NSAIDs, pain relievers, or decongestants.
• DON’T consume alcohol while taking this multi-symptom product.

Frequently Asked Questions

References

• U.S. FDA Label Information for Advil Allergy Sinus (Ibuprofen 200 mg, Chlorpheniramine Maleate 2 mg, Pseudoephedrine HCl 30 mg Tablets).
• U.S. FDA Drugs@FDA – Application Number: 021441, Initial Approval Date: December 2002.

Legal Disclaimer

This educational document is intended for informational purposes only and does not substitute for formal medical advice, clinical diagnosis, or specialized treatment. Always consult a qualified physician, allergist, or pharmacist with specific questions regarding upper respiratory symptoms, multi-symptom sinus products, or over-the-counter drug administration.